Alfonso Bellacosa

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Circulating Tumor

Metastatic Breast Cancer

Top Venues

Advanced genetics (Hoboken, N.J.)

Science signaling

This page only lists publications with an associated author ORCID identifier.

Publications

Alison N Kurimchak, Carlos Herrera-Montávez, Sara Montserrat-Sangrà, Daniela Araiza-Olivera, Jianping Hu, Ryan Neumann-Domer, Mathew Kuruvilla, Alfonso Bellacosa, Joseph R Testa, Jian Jin, James S Duncan
The drug efflux pump MDR1 promotes intrinsic and acquired resistance to PROTACs in cancer cells. Science signaling 15 (749) (2022)
Atsushi Onodera, Edahí González-Avalos, Chan-Wang Jerry Lio, Romain O Georges, Alfonso Bellacosa, Toshinori Nakayama, Anjana Rao
Roles of TET and TDG in DNA demethylation in proliferating and non-proliferating immune cells. Genome biology 22 (1) (2021)
Rahul M Prasad, Timothy J Yen, Alfonso Bellacosa
Active DNA demethylation-The epigenetic gatekeeper of development, immunity, and cancer. Advanced genetics (Hoboken, N.J.) 2 (1) (2020)
Rahul M Prasad, Timothy J Yen, Alfonso Bellacosa
Active DNA demethylation-The epigenetic gatekeeper of development, immunity, and cancer. Advanced genetics (Hoboken, N.J.) 2 (1) (2020)